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The relationship between estrous phase and immune response in female rats was 
studied using two designs. In the between subjects design, groups of five rats were 
tested for antigen binding capacity and estrous phase on each of the ten days 
following secondary exposure to an HSA antigen. In the within subjects design, 
fourteen rats were tested for estrous phase at time of antigen exposure and for 
antigen binding capacity on each of the ten days following secondary exposure. 
Estrous phase was determined from microscopic examination of vaginal smears and 
phases were categorized according to high or low levels of estrogen and prog- 
esterone. Both designs showed a significant increase in immune response over the 
ten days. The within subjects design showed that higher estrogen levels at the time 
of antigen exposure were accompanied by elevated immune response. This finding 
shows that naturally occurring fluctuations in estrogen level at the time of a 
challenge to the immune system have an influence on the immune response. 
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Introduction 
Female mammals characteristically demonstrate immunological responses 
which are superior to and more variable than that of males (Terres, Morrison, & 
Habicht, 1968; Kemiy & Gray, 1971; Krzych, Thurman, Goldstein, Bressler and 
Strausser, 1979; Ahmed, Penhale and Talal, 1985; Schuurs & Verheul, 1990; Falter, 
Persinger and Reid, 1991). Such sexual dimorphism in immunological responding 
may be either phylogenetically or ontogenetically determined. That is, the source 
of the dimorphism may be related to predetermined factors such as genetic 
programming of structural/functional contributants to immunity, or factors arising as 
the organism develops, such as the hormonal events triggered by sexual maturity. 
Clarification is required surrounding the origin of the dimorphism. 
The Immune System: A Brief Overview 
The immune system is a complex physiological system that has been 
broadly categorized into two types of immune responses, specific and 
nonspecific, involving different mechanisms of defense against invading, 
infectious organisms. Nonspecific immune responses, which are characterized as 
imiate, are present prior to exposure to the invading organism and are 
indiscriminant. Specific immune responses, which are characterized as acquired, 
are induced or initiated by the presence of invading organisms and other 
molecules, known as antigens. Antigens are molecules or parts of molecules 
which induce a specific immune response. Specific immunity has been 
subdivided into two response systems according to the types of immune cells 
involved in a given immune response. These subdivisions are referred to as 
cellular immunity, involving immune cells called T-cells, and humoral immunity, 
involving immune cells called B-cells. When activated by the presence of an 
antigen, the humoral system produces protein molecules known as antibodies, or 
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iiTaminoglobulins. Antibodies bind to antigens and produce a complex which 
triggers other cells of the immune system called phagocytes, macrophages and the 
complement system of proteins, to eliminate the antigen by destroying it 
(Grossman, 1984; 1985). 
Numerous quantitative measures of humoral and cellular immune function have 
been developed. There are a number essential steps in quantification of an immune 
response, that are shared by all measurement systems. First, the immune system must 
be prompted to respond by administration of an antigen. The most common types of 
antigens include foreign proteins and cells, such as human semm albumin (HSA) and 
sheep red blood cells (SRBC) in rodents, and bacteria such as E. Colt or Brucella. 
Second, the immune response elicited by antigen administration must be measured. 
The nature of this measurement depends on the type of antigen used and the particular 
component(s) of the immune system that are stimulated by the antigen. Two commonly 
used assays, or measurement systems, of humoral immunity are radioimmunoassay 
(RIA) and hemolytic plaque assay (HPA). The RIA teclmique involves the principle 
that antigen (Ag) - antibody (Ab) binding are in dynamic equilibrium, as follows: Ab + 
Ag c:> Ab-Ag. A mixture of radioactively- labeled antigen with antibody containing 
semm and known or unknown amounts of unlabeled antigen is incubated to allow 
antigen and antibody to reach binding equilibrium. The bound antigen is then separated 
from the unbound antigen. The amount of radioactivity of the bound antigen then 
provides a direct measure of antibodies in the semm. The HPA technique involves the 
use of red blood cells (RBC), or erythrocytes, which bind to antibody-producing cells, 
or lymphocytes, when incubated in a supportive medium with the lymphocytes. The 
addition of the cell-lysing protein, complement, then produces areas of cell lysis, or 
"plaques” in the medium surrounding the antibody-producing cells. Measurement of 
responses of T-cells and B-cells to substances called mitogens is another commonly 
used technique used to measure immune ftmction. Mitogens, which are groups of 
3 
plant substances, stimulate immune cells by inducing cell division. The mitogen 
phytohemagglutinin (PHA) stimulates T cells, whereas the pokeweed mitogen 
stimulates B cells and T cells. This assay involves the addition of a known quantity of 
mitogen to a sample of immune cells, after which division of the immune cells is 
measured. 
The Influence of Gender on Immunity 
The 1960's and early 1970's heralded much of the seminal research that 
established the gender differences in immunity. Researchers explored the 
foundations of such differences using human and animal subjects. Terres, Morrison 
& Habicht (1968) observed and quantified differences in immune responses 
between male and female mice. They injected a foreign protein called bovine 
semm albumin (BSA), then measured the antibodies produced in response to the 
BSA antigen. The results indicated that females produced 10-85 times more 
antibody than the males, that female antibody responses were of longer duration and 
that females responded to smaller doses of the antigen than males. These findings 
suggested that differences existed in antibody levels between male and female 
mice. Terres et al. (1968) postulated that the differences they observed could have 
arisen from a greater efficiency of phagocytes in females. This explanation is 
consistent with the findings of Nicol (1932), (1935) and Nicol and Bilbey (1960), 
which showed that the action of phagocytes is greater in females and under the 
control of the sex honnone, or steroid, estrogen. 
Rhodes, Scott, Markham and Monk-Jones (1969) examined the 
immunological responses of male and female rheumatoid arthritis patients, the 
patient's relatives, and a group of control subjects devoid of inflammatory disease. 
Brucella vaccine was administered to all three groups as a means of eliciting a 
measurable immune response. The results showed that in all groups the mean levels 
of antibody produced in response to the Brucella vaccine were higher in females. 
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Similarily, Michaels and Rogers (1971), examined the immune responses of two 
groups of infants, aged 6-9 and 11-14 months and assayed the blood samples for 
their reactivity to five E. Coli bacteria types. They found that the antibody levels, 
produced in response to the E. Coli bacteria, were higher for females in both age 
groups of infants. The greater antibody responses of infant females to bacteria, at 
least partially supports the phylogenetic origin of gender differences in immunity 
insofar as these subjects have not been exposed to the levels of circulating honnones 
associated with sexual maturation that have been hypothesized as a potential source 
of the sexual dimorphism in immunity. 
Kemiy and Gray (1971) examined the antibody responses of male and female 
mice to the bacteria E. Coli. In a series of experiments, the mice were infected with 
the E. Coli bacteria and antibody production by the spleen cells was measured using 
the hemolytic plaque assay. The results supported generally supported a better 
ability of female mice to respond immunologically, with the following observations: 
weanling female mice produced more antibodies than their male littennates, the 
antibody response of females, and not males, increased with age, female mice 
produced antibodies to a small amount of antigen for which the male mice were non- 
responsive, ovariectomized mice responded just as their sham-operated male 
counterparts to a small dose of antigen and estradiol administered to weanling male 
mice enlianced their antibody production. Additionally, administration of small 
doses of estrogen to weanling male mice enlianced antibody production. Kenny and 
Gray hypothesized that their results could be explained by the influence of female 
sex honnones on the immune system. They asserted that their observations of 
gender differences in immunity in sexually immature mice were consistent with the 
hypothesis, given the secretion of sex honnones in sexually immature mice. 
Similarily, Eidinger and Garrett (1972) examined the immune responses of male 
mice, female mice, and males castrated at 6 weeks of age. The responses to various 
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types of antigens were measured in order to quantity and compare different aspects 
of the immune response. Female mice exhibited greater antibody production than 
male mice. Castrated male mice demonstrated immune responding comparable to 
that of female mice, thus converting the males to females with respect to their 
immune responses. The investigators concluded that sex hormones influenced 
immune responding. 
Krzych, Thunnan, Goldstein, Dressier and Strausser (1979) evaluated the 
responses of immune cells from various immune system organs, including the 
thymus, lymph nodes, and spleen in newborn, weanling and young adult male and 
female mice. The results showed no gender differences in the immune response in 
the weanling mice. Gender differences in immunity observed in the young adult 
mice were assay-specific. The gender differences obtained were specific to the 
spleen. Krzych et al. (1979) concluded that the immune system organs exhibit a 
differential sensitivity to the influence of the sex honnones, and that this differential 
sensitivity underlies the sex-related differences in immunity. Additionally, the 
authors asserted that the direct relationship between strength of sex-related 
difference in immune response and age of the animal, strongly suggested a "parallel 
relationship between immune response and sexual maturity." (p. 2572). According 
to Krzych et al., the superior immune responsiveness of females, dependent on or 
triggered by sexual maturation, could be attributed to the apparent immuno- 
enliancing properties of the female sex honnones, which become active at the time 
of sexual maturation. 
Using male and female rats, Falter, Persinger and Reid (1991) examined antibody 
production in response to human serum albumin (HSA) antigen. The female rats 
showed higher and more variable antibody responses to HSA. Specifically, the females 
exhbited twice the antibody production of males, and a tenfold amplification of antibody 
production compared to males when the antigen activity of the HSA was enlianced by 
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the addition of rat spinal cord emulsion called Freund's adjuvant. Castration of post- 
weanling males failed to stimulate the level of antibody production exhibited by the 
female rats. The results with the castrated males ruled out testosterone as a factor 
mediating the immunological gender differences observed in rats. To test the potential 
influence of sex honnone fluctuation on antibody production in female rats. Falter et al. 
sacrificed the rats at the peaks and nadirs of their activity cycles, which cohere strongly 
to discrete stages of the estrous cycle. Antibody production was not altered according 
to peak or nadir of the activity cycle. The results supported a phylogenetic basis for 
immunological gender differences, given that measures and inferences of adult male and 
female gonadal honnonal fluctuations did not appear to mediate variable antibody 
production. 
Collectively, the literature provides ample support for the immmiological 
superiority of female rodents and humans relative to their male counterparts. 
Researchers have linked this superiority and greater variability to the influence of 
sex hormones, such as estrogen, that produce significant physiological changes at 
the time of sexual maturation (Krzych et al., 1979). However, the findings of other 
researchers suggests that fluctuating sex honnones in the adult female, associated 
with sexual maturation, are not the primary source of immunological gender 
differences, given the observations of sex differences in immunity prior to sexual 
maturation (Michaels & Rogers, 1971; Kemiy and Gray, 1971). 
The Influence of Estrogen & Progesterone on Immunity 
Estrogen and progesterone have multifactorial and, in many respects, 
complementary roles in preserving the integrity and assuring the survival of the 
organism. Both honnones are involved in the maintenance of the reproductive cycle 
in mammals, exliibit cyclicity. Estrogen, an ovarian honnone, plays a role in cellular 
growth and proliferation, in addition to supporting the development of secondary 
sex characteristics of females. Progesterone, also an ovarian honnone, complements 
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estrogen by suppressing and limiting growth and proliferation of cells, except during 
pregnancy when progesterone acts to promote the growth and development of the 
fetus (Wade, 1971). Although in unique ways, both estrogen and progesterone 
contribute to survival and perpetuation of the species. During pregnancy in 
mammals, for instance, when progesterone levels are high relative to estrogen 
levels, some degree of maternal immunosuppression is beneficial and adaptive to 
the survival of the newly developing organism. Likewise just before ovulation, 
when estrogen levels are high relative to progesterone, it is of some advantage for 
the immune system to be alert to foreign material introduced by virtue of 
intercourse. 
Whether estrogen produces immunofacilitation or immunosuppression 
appears to depend on the concentration of estrogen used in in vitro or administered 
in vivo, the timing of the injection of the honnone relative to activation of the 
immune response by antigen injection, the immune parameter measured and the 
developmental stage, and age of the organism. Kenny, Pangbum and Trail (1976), 
injected E. Coli bacteria into male weanling mice and measured antibody production 
by the spleen . To clarify the role of estrogen in modulating the antibody-producing 
process, 17(3-estradiol, an estrogen analog, was administered at the time of injection 
of the E. Coll and following the development of an immune response to the E. Coli. 
The concentration of estradiol and the timing of administration were significant 
variables influencing the magnitude of antibody-production. Small concentrations of 
estradiol stimulated division of antibody-producing cells, whereas larger 
concentrations of estradiol suppressed division of antibody-producing cells. 
Administration of estradiol 1 day before and up to 3.5 days after injection of the E. 
Coli increased the numbers of antibody-producing cells, whereas administration of 
estradiol 2 days before the antigen had no effect. The differential effect of the 
timing of estradiol administration, was attributed to the relative serum levels of the 
8 
estradiol at the time of the antigen injection. Serum levels of estradiol slightly above 
the physiological range at the time of antigen delivery, as was obtained with 
injection of estradiol 2 days before antigen delivery, had no effect on antibody- 
producing cells. Administration of estradiol 1 day before and up to 3.5 days 
following injection of the antigen, however, increased numbers of antibody- 
producing cells. 
To assess the effects of neonatal estrogen treatment on adult immuno- 
responsiveness, Kalland, Strand and Forsberg (1979) administered 17(3-estradiol (10 
pg) and diethylstilbestrol (DES) (0.01 pg, 0.1 pg, 1 pg, 5pg), a synthetic estrogen, to 
5 groups of female mice for 5 days post partum, with each group receiving a 
different dose. Treatment of neonatal mice with DES resulted in a protracted 
impainnent of spleen cell responsiveness to mitogens, as far as 17 months later in 
DES treated females, compared to controls. Of all the DES doses, and including the 
estradiol, the 5 ug dose of DES was the only one which resulted in suppressed 
splenic mitogen responses post-infancy. DES (5pg) administered for five 
consecutive days from day 6 through 10 post-partum, did not influence the post- 
infancy splenic mitogen response. Luster, Boorman, Dean, Luebke, and Lawson 
(1980) administered 3 doses of diethylstilbestrol (DES), (0.2 mg/kg, 2.0 mg/kg, 8.0 
mg/kg), to adult female mice and measured splenic antibody responses to SRBC 
antigen and found that only the 2.0 and 8.0 mg/kg doses of DES had reduced 
antibody levels relative to controls. Those mice that received lower doses of DES 
had antibody levels similar to controls. Luster, Hayes, Korach, Tucker, Dean, 
Greenlee, and Boonnan (1984) provided further evidence of the potency and 
specificity of estrogen compounds in modulating immunity. They administered the 
compounds DES, 17(3-estradiol, 5a-dienestrol, 5a-dihydro- testosterone (5a-DHT) 
and progesterone, classified by the investigators as estrogenic compounds, to adult 
female mice. Each group of mice was exposed to one of the five compounds for 
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five consecutive days. Macrophages and lymphocytes from the spleens of the mice, 
were quantified following exposure of the mice to the compounds described. The 
results showed a positive correlation between magnitude of influence on immune 
response and estrogenic activity. Specifically, both DES and 17p-estradiol 
activated lymphocyte and macrophage function of spleen cells, with DES the more 
potent activator. 5a-dienestrol also increased splenic macrophage and lymphocyte 
frinction, whereas 5a-DHT and progesterone had no effect on splenic macrophage 
/lymphocyte frinction. The results of all three studies support dose-dependent effect 
of exogenous, administered estrogens on cellular and humoral immune responses. 
Kalland, Strand and Forsberg (1979) demonstrate that the effect of exogenous 
estrogen is not only dose-dependent but dependent upon the maturity of the 
organism, and more specifically, the maturity of the organism's immune system. 
Hu, Mitcho, and Rath (1987) investigated the effects of 17p-estradiol on the 
synthesis and secretion of interleukin 1 (IL-1), a chemical messenger in the immune 
system, in rats, and found an increased IL-1 synthesis by peritoneal macrophages in 
adult female rats relative to age-matched male and prepubescent female rat controls 
and increased lL-1 synthesis in ovariectomized female rats exposed to 17p-estradiol 
replacement therapy. Furthermore, treatment of male peritoneal macrophages with 
17p-estradiol stimulated lL-1 synthesis at low doses and inhibited it at high doses, 
relative to controls. These results indicate that estradiol modulation of lL-1 
synthesis by peritoneal macrophages may contribute to the greater immunological 
response observed in females. 
Investigations exploring the immunomodulatory properties of progesterone 
are minimally represented in the literature relative to the documented immuno- 
modulatory properties of estrogen and related compounds. There is a significant 
amount of literature showing that progesterone suppresses immune function during 
pregnancy (Bratanov and Vulchanov, 1986), however the evidence demonstrating 
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the influence of progesterone in normal physiology is more mixed and less 
prevalent. An inference of this may be that the immunomodulatory role of 
progesterone is less obvious, masked by a possible co-immunomodulatory or 
synergistic function in which the more potent immunomodulator, estrogen, would 
dominate the immunomodulation. 
Munroe (1971) injected monkeys with the Rous chicken sarcoma virus 
(RSV) and administered progesteroids, a group of compounds with progesterone 
activity, to groups of the monkeys as follows: progesterone (5 mg/kg), 
medroxyprogesterone (10 mg), nortestosterone (5-15 mg) and medrogestone (10 
mg/lb). The latency for tumours to develop was measured for each group. Groups 
of pregnant monkeys and untreated control monkeys were also observed for latency 
of tumour induction. Thirty out of 34 progesteroid treated groups of monkeys, 
including 5 out of 5 pregnant monkeys, developed tumours, whereas 0 out of the 22 
control monkeys developed tumours in response to inoculation with RSV. Munroe 
concluded that both exogenous, administered progesteroids and endogenous 
progesterone, as in the case of elevated levels of progesterone in pregnancy, have a 
potent immunosuppressive effects. 
Wybran, Bogaert, and Govaerts (1977) examined the effects of the synthetic 
progesterone, lynestrenol, on in vitro human lymphocyte responses. Lymphocytes 
were obtained from the blood of nonnal adult male and female subjects. To 
quantify lymphocyte function, the lymphocytes were exposed to two types of 
mitogens, pokeweed mitogen and phytohemagglutinin (PHA), in order to measure B 
and T-cell responses. Lymphocytes were exposed to varying doses (0.1 pg/ml - 10^ 
pg/ml) of synthetic progesterone for varying lengths of time, up to a maximum of 7 
days. The results showed that lynestrenol did not modify the responses of the 
lymphocytes to either mitogen. However in the presence of PHA, the lynestrenol 
(10^ to 10 ') increased lymphocyte incorporation of a radioactively-labeled DNA 
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tracer, ^H-thymidine. Although not directly involved in the modification of human 
lymphocyte responses to mitogens, lynestrenol seemed to activate lymphocytes in 
response to the T-cell specific mitogen, PHA, as indicated by the thymidine 
incorporation. Progesterone may then be involved in limited aspects of immune 
modulation, limited to amplification and not initiation of immune T-cell division. 
In a subsequent examination of the effects of lynestrenol on immunity, 
Wybran and Thiry (1978) administered 1.0 mg/kg, 0.1 mg/kg and 0.01 mg/kg 
lynestrenol to groups of male and female newborn hamsters. The hamsters were 
inoculated with herpes simplex virus type 1 (HSV 1) one day after the beginning of 
lynestrenol treatment, and the development of subcutaneous tumours was monitored. 
The results indicated that the 1 mg/kg dose of lynestrenol delayed tumour growth in 
the cells affected by HSV 1. Another group of 4 week old hamsters were 
vaccinated 2 times at one week intervals with heat-killed HSV 1, treated with 1 
mg/kg of lynestrenol from 2 days before the first vaccine to 2 days after the second 
vaccine, then challenged with viable HSV 1. The vaccination- facilitated tumour 
growth was inhibited in lynestrenol-treated hamsters. The results of delayed tumour 
growth appeared to suggest immunopotentiating properties of lynestrenol, while the 
data from the vaccinated hamsters appeared to suggest immunosuppressive activity. 
The authors reconcile this apparent contradiction by postulating that lynestrenol may 
indeed be immunosuppressive. Consistent with this, the immunopotentiating 
properties of lynestrenol can be accounted for by a mechanism involving the 
lynestrenol-facilitation of specific class of immune cells, called T-suppressor cells, 
which act to suppress immunity. 
In summary, both natural and synthetic estrogens and progesterones have 
been shown to be immunoregulatory. The direction, extent, and nature of this 
regulation is likely dependent on a host of variables such as type of honnonal 
treatment, biochemical similarity of synthetic honnones to physiological honnones. 
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dose of homional treatment, timing of hormonal treatment relative to initiation of 
imimine response, and parameter of immunity measured. Some evidence supports a 
synergistic role between progesterone and estrogen in modulating the immune 
system during normal, non-pregnant, physiological functioning. Estrogen clearly 
has very potent immunomodulatory properties, immunofacilitory for the most part, 
whereas progesterone may serve as a co-modulator under regular physiological 
conditions, possibly acting with subtle immunosuppressive properties, which 
become enhanced during specialized conditions such as pregnancy. 
The Influence of the Estrous Cycle on Immunity 
Collectively, the literature has demonstrated that estrogen and progesterone 
modulate immune fmiction, estrogen to a greater extent, and that this capacity 
appears at the time of sexual maturation in the female, when the menstmal or 
estrous cycles become active. Serum levels of estrogen and progesterone fluctuate 
during the monthly reproductive (ovarian) cycle in female mammals, producing the 
menstrual cycle in humans and estrous cycle in rodents. Evidence that levels of 
estrogen and/or progesterone contribute to the superior and more variable female 
imimine response, coupled with quantifications of estrogen and progesterone levels 
during the estrous cycle, such as those by Butcher, Collins and Fugo (1974), have 
prompted and assisted with investigations of the impact of estrous-related 
fluctuations in estrogen and progesterone on immune flinction. 
One study that demonstrated the influence of the hormonal events associated 
with the estrous cycle on immune response was conducted by Black, Simon, 
McNutt and Casida (1953). The authors injected rabbit semen contaminated by E. 
Coli and staphylococcus bacterium into the uteri of two groups of rabbits: one group 
consisted of pseudo pregnant rabbits, in which there is no estrous as a result of an 
infertile copulation; the other group consisted of rabbits in the estrous, a fertile stage 
of the estrous cycle. The pseudo-pregnant rabbits showed pus formation in the 
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utems in response to the infected sperm, whereas the rabbits in estrous did not. 
Rabbits treated with estrogen/progesterone or progesterone alone, developed an 
accumulation of pus in the uterus, whereas the rabbits treated with estrogen alone 
did not. These results suggest that under conditions where the influence of the 
ovarian cycle, and its associated hormonal correlates, is removed, as in the case of 
pseudo-pregnancy, the inumine resistance is impaired. Accordingly, estrogen may 
promote immunofacilitation, thereby supporting the body's natural defense, while 
progesterone may iiiliibit this natural defense. 
Nicol and Vemon-Roberts (1965) examined the influence of the estrous cycle 
and ovariectomy on immune function in female mice and rats. They measured 
activity in the reticuloendothelial system (RES), which is a population of immune 
cells located throughout the body in both imiuune-related organs and other tissues, 
that Einction to phagocytize invading organisms. Estrous stage was determined 
using a method based on examination of predominant types of epithelial cells 
obtained from a vaginal smear. The follicular phase (proestrous) was characterized 
by predominant round, nucleated epithelium, estrous was characterized by 
predominant comified epithelium, the luteal phase (metestrous) was characterized 
by predominant comified epithelium with the presence of leukocytes, or white blood 
cells, and diestrous was characterized by predominant round, nucleated epithelium 
and leukocytes. Nicol and Vemon-Roberts observed two peaks in the RES activity 
in both mice and rats during follicular and luteal phases of the estrous cycle, 
corresponding to proestrous and metestrous stages of the estrous cycle, respectively. 
Ovariectomy abolished the observed peaks of RES activity in mice. Without the 
benefit of quantification of hormone levels in mice and rats during stages of the 
estrous cycle, the authors assumed that the observed peaks in RES activity 
corresponded to peaks in semm estrogen in the rodents. This assumption was based 
upon their postulation that estrogen acted as the body's natural stimulant of 
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iimnunity. Later, Krzych, Straiisser, Bressler and Goldstein (1978) measured the 
response of splenic lymphocytes to mitogens and splenic antibody production to 
SRBC antigen during the stages of the estrous cycle in female mice. The 
investigators knew from Butcher et al. (1974) that in the estrous cycle of the rodent, 
estrogen levels were highest during proestrous and diestrous phases whereas 
progesterone levels were highest during proestrous and metestrous phases. In their 
investigation, Krzych et al. (1978) showed that both mitogenic and antibody 
responses were elevated at proestrous relative to diestrous and at metestrous relative 
to estrous. Collectively, the findings of Krzych et al. (1978) and Nicol and Vemon- 
Roberts (1965) provide evidence of two peaks of immunoresponsiveness, occurring 
during proestrous and metestous phases of the estrous cycle. The peaks correspond 
to high estrogen/high progesterone (proestrous) and high progesterone/low estrogen 
(metestrous). 
De and Wood (1990) analyzed the distribution of immune cells called 
macrophages through different stages of the estrous cycle in the mouse. The 
distribution of uterine macrophages changed from one stage to the next tlirough the 
stages of the estrous cycle. In order to determine whether estrogen and 
progesterone were involved in producing these distributional differences, the 
distribution of uterine macrophages were analyzed in ovariectomized females. The 
investigators observed that the number of uterine macrophages was decreased 
relative to controls but could be restored with the administration of progesterone or 
estrogen. The results support the influence of the ovarian honnones estrogen and 
progesterone as having the capacity to affect number and distribution of immune 
system cells during the estrous cycle. Furthennore, Brown, Sundstrom, Komm, 
Teuscher, and Lyttle, (1990) investigated the hormonal regulation of complement 
(C3). Complement proteins comprise a complex system is activated by antibody- 
coated cells to lyse the antibody-coated cells. Uterine complement activity was 
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measured during stages of the estrous cycle. In a separate experiment, uterine C3 
was measured following the administration of ovarian honnones according to the 
following protocol; estradiol alone, estradiol and progesterone, and progesterone 
alone and controls (untreated). The results showed that C3 activity was highest 
during the estrogen-dominated stages of the estrous cycle, namely, proestrous and 
estrous and lowest during diestrous. They also demonstrated that estradiol 
produced a progesterone-reversible increase C3 relative to controls, whereas the 
progesterone had no effect. The estradiol-induced increase in C3 could be reversed 
by the coadministration of progesterone. The findings of Brown et al. concur with 
those of De and Wood, who also observed immunomodulation by endogenous, 
estrous-associated ovarian hormones, corroborated by similar immune effects of 
externally administered ovarian honnones. Generally, the results support immuno- 
modulation by the ovarian honnones associated with the estrous cycle in rodents. 
Mukherjee, Mastro, and Hymer (1990) demonstrated that in female rats the 
peptide honnone prolactin, which is normally secreted during pregnancy to promote 
the secretion of milk, induced the formation of receptors on spleen cells. The 
receptors were specific for IL-2, a specific chemical messenger in the immune 
system and the induction was dependent on estrous phase of the rat. Specifically, 
ovariectomized rats or rats in diestrous demonstrated a receptor-induction response to 
prolactin, while estrogen-treated ovariectomized rats or rats in estrous did not. These 
findings not only support Hu et al. 's (1987) observations that externally administered 
estrogen modulates the interleukins but that the resulting immunomodulation depends on 
the availability of circulating estrogen. 
In addition to direct influence of naturally-occurring, estrous-associated estrogen 
and progesterone on immune function, there is evidence supporting the existence of a 
neuroanatomical pathway through which hormonally-detennined immune regulation can 
occur. Pfaff and Keiner (1975), Rainbow, Parsons, MacLusky and McEwen (1982) and 
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Lipositis, Kallo, Coen, Pauli and Flerko (1990) independently reported estrogen 
receptors in limbic and hypothalamic structures known to be involved in the central 
regulation of immunity (Jankovic and Isakovic, 1973; Schleifer and Shapiro, 1986; 
Besedovsky, Rey and Sorkin, 1985). Kelly, Moss and Dudley (1977) showed that 
iiiRision of 17p-estradiol into immuno- regulatory areas in the hypothalamus altered the 
electrical activity in an estrous-stage dependent fashion. The hypothalamic cells were 
electrically stimulated by 17p-estradiol during metestrous and electrically inliibited by 17 
P-estradiol during diestrous, proestrous and estrous. Collectively, these data may 
indirectly support a mechanism whereby naturally-occurring circulating estrogen and 
progesterone associated with the estrous cycle may influence immunity. That is, estrogen 
and progesterone may influence immunity by their action in the central nervous system, 
as well as at the cellular level. 
Although there is adequate support for the immunomodulatory properties of 
estrogen and progesterone, it remains unclear which phases of estrous are associated with 
enhanced or suppressed immune fimction, particularly for the modulation of antibody 
responses. 
The Present Study: Design and Main Hypotheses 
This study was designed to clarify what effects the estrous cycle exerts on 
antibody responding in intact female rats, and to determine if the estrous phases 
associated with higher levels of serum estrogen or progesterone had any differential 
impact on such responding. Relative levels of circulating ovarian steroids (estrogen, 
progesterone) were based on the findings of Butcher, Collins and Fugo (1974), who 
quantified levels of estrogen and progesterone during each phase of the estrous 
cycle in the rat. 
Two designs were used. The immune response to be measured was initiated 
by two injections of a protein antigen called human semm albumin (HSA). The first 
injection of ITSA acted to prime the rats, or set up an initial immune response. The 
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second (booster) injection, which typically results in an immune response that is 
more robust and measurable, was the response measured in this study. Because the 
immune response generally asymptotes around ten days following a booster 
injection of protein antigen, only the first ten days following the second injection 
were examined. The first design used a cross-sectional approach, in which different 
groups of 5 rats were tested on each of the 10 days following secondary exposure. 
This design yielded a direct measure of estrous phase at the time the iimmme 
response was being measured. The second design used a longitudinal approach in 
which the estrous stage at the time of secondary exposure was measured in 15 rats, 
and these same rats were repeatedly sampled for secondary immune response for the 
10 days following exposure. 
Based upon review of the literature, it was hypothesized that the estrous 
stages associated with high semm estrogen levels will increase antibody levels 
relative to those estrous stages associated with low semm estrogen levels, and that 
the estrous stages associated with high serum progesterone levels will decrease 
antibody levels relative to those estrous stages associated with low semm 
progesterone levels. In other words, it is hypothesized that estrogen will be 
iimmmofacilitating and progesterone immunosuppressing. The cross-sectional and 
longitudinal designs have been used to explore the dynamics of a possible 
interaction between estrous phase and antibody response. The cross-sectional and 
longitudinal designs were used to determine whether the estrous phase at the time of 
antigen exposure (cross-sectional), or at the time the antibody response is measured 




A total of 65 female Wistar rats (age 80 days) obtained from Charles River 
Suppliers, served as subjects. They were housed in standard wire cages (3/cage) in 
temperature and light (12:12 LD) controlled rooms, with food and water available 
ad libitum. 
Methodological Overview 
The method used in the study was adapted from previous investigations in 
which the current author was primary author and active researcher (Reid, Falter and 
Persinger, 1991; Falter, Persinger and Reid, 1991). 
Immunization and Blood Collection 
The animals were permitted ten days to habituate to housing conditions then 
inoculated subcutaneously in the right flank with an homogenized solution of 0.1 mL 
human serum albumin (HSA) (10 ug/mL) and 0.1 inL complete Freund's adjuvant 
(CFA). Eighteen days later, 100-200 uL of blood was removed from the caudal vein 
of each subject, which was followed by a second identical injection of HSA. The 
second HSA injection did not require CFA as an immune response facilitator 
because second exposures to antigens reliably produce a robust response. Blood 
collection involved immobilization of the subject using a plastic restraint cage, 
dilation of the vasculature by immersion of the tail in water at 50 °C for 
approximately 30 seconds, and withdrawal of blood using a 26.5 guage hypodemiic 
tip. The blood was removed from the hypodenuic tip using a pasteur pipette, placed 
in a Microtainer serum separator tube, to separate the antibody-containing semm 
from the cells, centrifuged at 3000 g for ten minutes, then stored at 4 °C for later 
analysis. 
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Estrous Phase Determination 
Estrous phase was determined by microscopic examination of vaginal 
epithelium cells. The method for determining estrous phase by classification of 
predominant epithelial cell types was adapted from Long and Evans (1922) and 
Harris and Kesel (1990). Smears of vaginal epithelium were obtained by gently 
flushing the vagina with distilled water (35-40 °C) expelled from a smooth tipped 
dropper. Triplicate sampling was perfonned for each subject, smeared across a 
standard glass slide and then left to air dry. A 0.5 % Toluidine Blue (in 20 % 
ethanol) stain was used in a standard staining sequence of 20 % ethanol, stain, 40 % 
ethanol, 60 % ethanol, 80 % ethanol, 100 % ethanol (dehydration phase) and xylene 
(clearing agent). The slides were then left to air dry for subsequent examination. 
Phase of the estrous cycle was determined by microscopic examination of the slides. 
Rating criteria were according to the predominant epithelial cell type observed in 
the smears (as outlined by Nicol & Vemon-Roberts, 1965). Initial categorization of 
estrous stage included the four stages, proestrous, estrous, metestrous and diestrous 
stages, or phases. These four stages were incorporated in a 2x2 design with respect 
to high or low levels of estrogen or progesterone, since proestrous is associated with 
high estrogen and progesterone, estrous with low estrogen and low progesterone, 
diestrous, with high estrogen and low progesterone, and metestrous with low 
estrogen and high progesterone (Butcher et al. 1974). The data were collapsed as 
follows; diestrous/proestrous = estrogen high, estrous/metestrous = estrogen low, 
metestroiis/proestrous = progesterone high, estrous/diestrous = progesterone low 
(Butcher et al., 1974). 
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Radioiodination of Protein Antigen THSA) 
Additional HSA antigen, to be used in the in vitro measurement of HSA 
antibodies, required labeling with a radioactive material in order to facilitate the 
identification of relative levels of HSA antibodies in the rat sera. A 6 mg/mL 
solution of freeze dried human serum albumin (HSA) dissolved in a sodium 
phosphate buffer, pH 7.2, 0.15 mol/L, was prepared immediately prior to the mixing 
of the following reagents in a single reaction vile, or small v-shaped tube; phosphate 
buffer, pH 6.5, 0.2 mol/L (50 jUL), Enzymobead reagent (50 jUL), Beta D-glucose 
solution (25 jjL), Nal* specific activity 17.4 Ci/mg. Specific activity, measured in 
the unit Curie per unit mass, reflects the relative amount of radioactive disintegration 
per unit mass. A volume of 50 fjL of the HSA solution was then added to the 
reaction vile, and the reaction was allowed to proceed for one hour at room 
temperature. The reaction was quenched, or brought to an end point, by applying 
the mixture to a G-25 superfine Sephadex gel filtration column. 
The cohiimi was prepared in advance by adding 12 grams of G-25 superfine 
powder to phosphate buffer, pH 6.5, 0.2 mol/L (75 mL), which was gradually 
applied to the column and equilibrated by passing through a phosphate buffer. Prior 
to use of the column, nonspecific binding sites, which would inliibit the column fi:om 
binding unlabelled HSA, were eliminated by passing through an HSA solution, and 
the flow rate was adjusted to 4-5 mL/tube/20 minutes. Samples (20 jjL) of the 
fractions collected from the addition of the reaction mixture were then counted using 
a gaimna scintillation counter to determine the location of the precipitated labeled 
protein (*T-HSA) (samples with highest cpm's). 
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Biochemical Analysis 
The antigen binding capacity (ABC) of the rat sera was determined by 
modification of a method described by Farr (1958). Test serum (or appropriate 
dilutions of test serum) (20 ji/L), carrier serum from control animals (20 /iL), 1.1 
ug/mL *I-HSA (radioactively labeled) (20 jjL), and phosphate buffer, pH 7.2, 0.15 
mol/L (60 iJh) were incubated for two hours at 37 °C. Phosphate buffered saline, 
pH 7.2 (380 ji/L) was added, followed by saturated ammonium sulphate. This was 
allowed to stand at room temperature for 15 minutes, then centrifriged at 3000 g for 
30 minutes. The supernatant was discarded and the precipitate washed with 
saturated ammonium sulphate (50 %) (500 jjL). This was followed by another 
centrifrigation (room temperature, 3000 g, 10 minutes) and disposal of supernatant. 
The gamma emission of the resulting pellet was measured using a gamma 
scintillation counter. 
Calculation of Antigen Binding Capacity (ABC) 
In order to detenuine the antigen concentrations in unknown samples, namely 
the antisera from subjects, a standard curve was constructed as follows: for each 
series of dilutions, the percent of precipitate was plotted on a logarithmic scale 
against the inverse of the dilution. The dilution required to produce 33 % 
precipitate, reflecting a region of in the antigen-antibody reaction in which the 
antigen is in excess of the antibodies, was determined by graphical interpolation. 
The antigen binding capacity (AJBC) expressed in fJg/mL (semm), was calculated 
according to the fonmila: 
ABC=(A/g *I-HSA) (% precipitate/100) (50) 
Rat sera that gave less than 10 % precipitate were identified as non- 
responders and not included in the data. The a priori definition of a response (to the 
antigen) was an ABC of at least 0.11 jUg/ml on the day of the baseline sample. 
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Procedure 
Both cross-sectional (between subjects) and longitudinal (within subjects) 
groups received identical injection protocols: initial injection of antigen + adjuvant 
followed by a second injection of antigen alone, which produces the more robust 
secondary response that was measured in this study. The second injection of 
antigen, known as the booster injection, is typically administered as the primary 
response begins to attenuate, which is usually three weeks post primary injection 
(Falter at al., 1991), 18 days post-primary in the current investigation. The groups 
differed only with respect to the timing of vaginal epithelium and blood collection 
protocols. 
Cross-sectional (between subjects) groups, which comprised 10 groups of 5 
rats, were sampled (vaginal epithelium/blood collection) sequentially, with each of 
the 10 groups sampled on one day of the ten days used as the period over which the 
antibodies were measured. That is, with one group representing each day of the 
secondary immune response, day 1 being the first day following the booster 
injection, or beginning of the secondary response, through day 10, at which time 
plateau/attenuation of the secondary response occurs. Longitudinal (within 
subjects) groups, which comprised 5 groups of 3 rats, 15 rats in total, were sampled 
(as above) on a daily basis such that each subject in this condition had an estrous 
stage measure and antibody measure for each day of the ten days of the secondary 
response. The actual group size for the longitudinal study was n=14 due to the 




Since the raw ABC measures typically show heterogeneity of variance due to 
positive skewness (Terres et al., 1968; Rliodes et ah, 1969; Falter et ah, 1991) log 
transformations of the data were used to stabilize the variance. Cross-sectional 
(between subjects) data were used to examine the influence of hormonal level at the 
time of testing whereas longitudinal (within subjects) data were used to test the 
influence of hormonal level at the time of the booster injection. For the second 
design, three way anovas were perfomied on the dependent variable log ALBC, with 
the independent variables being day (10 levels), estrogen (2 levels; high, low) and 
progesterone (2 levels; high, low). For the between subjects design, the small cell 
sizes did not allow for the examination of interaction terms. The within subjects 
design yielded a complete 3 way anova. 
Estrous phase categorizations used in the analysis to test the first hypothesis 
involving the exploration of the immunomodulatory influence of estrous phase at 
time of testing, were directly detennined by vaginal smear methodology on the day 
of blood collection. Estrous phase categorizations used in the analysis to test the 
second hypothesis involving the immunomodulatory influence of estrous phase at 
day 0, were detennined directly by vaginal smear methodology for the longitudinal 
subjects on the day of the booster injection of FISA. 
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Results 
Cross-Sectional (^Between Subjects) 
The means, standard deviations, and counts for the logio transformed 
measures of antigen binding capacity (ABC) for cross-sectional analyses are shown 
in Table 1. There was significant increase in ABC as a function of time (Day 0 
tlirough Day 10), F(9, 38) = 9.04, shown in Figure 1. This is characteristic of the 
secondary immune response. The effect size for the change in ABC values over 




Means, Standard Deviations of Log ABC and Numbers of Subjects 
Categorized According to Estrogen/Progesterone Levels @ Time of Testing, 





































































































































ANOVA Summary Table: 





































Overall Mean Log ABC as a Function of Days of Immune Response 
Following Booster Injection 


















Longitudinal Results (Within Subjects) 
The means, standard deviations and counts for the logio transformed measures 
of antigen binding capacity (ABC) are shown in Table 4. Concurrent with the 
cross-sectional data, there was a significant increase in ABC as a fiinction of time, 
F(9, 90) = 38.15, p = 0.00, shown in Figure 1. The effect size for the change in 
ABC values over time was 0.75. 
Repeated measures analysis of variance (summarized in Table 5 and shown in 
Figure 2) demonstrated a significant effect of day 0 estrogen levels, F(l, 10) = 7.65, 
p = 0.02, and no significant differences for day 0 progesterone levels, F(l, 10) = 
0.04, p = 0.85, on magnitude of subsequent humoral immune responding. 
Subjects with higher estrogen levels at the time of the secondary booster 
injection (Day 0), exliibited a relatively greater antigen binding capacity, whereas 
subjects with lower estrogen levels at Day 0, exhibited a relatively lower antigen 
binding capacity. Eta values indicated that the strength of the effect of estrogen- 
dominant estrous phases at the time of the injection, on subsequent humoral 
immune response, was equal to 0.41. The interaction of estrogen and days 
approached significance (p =.054), but after applying the Greenhouse-Geisser 















Means, Standard Deviations of Log ABC and Numbers of Subjects 
Categorized According to Estrogen/Progesterone Levels @ Day 0, 
Over the Ten Day Period of Immune Response Measurement 
(Within Subjects) 
Estrogen Progesterone 
Low High Low High 
M s.d. n M s.d. n M s.d. n M s.d. n 
0.50 0.12 9 0.97 0.32 5 
0.70 0.20 9 1.14 0.40 5 
0.84 0.23 9 1.28 0.48 5 
1.05 0.27 9 1.68 0.33 5 
1.15 0.45 9 1.83 0.28 5 
1.25 0.40 9 1.88 0.41 5 
1.32 0.34 9 2.06 0.41 5 
1.37 0.37 9 2.13 0.44 5 
1.32 0.44 9 2.00 0.38 5 
1.30 0.43 9 2.11 0.42 5 
0.89 0.41 4 0.58 0.22 10 
1.10 0.42 4 0.77 0.30 10 
1.25 0.55 4 0.89 0.28 10 
1.60 0.45 4 1.15 0.35 10 
1.69 0.47 4 1.27 0.50 10 
1.79 0.60 4 1.35 0.43 10 
1.92 0.67 4 1.45 0.39 10 
1.92 0.76 4 1.53 0.41 10 
1.83 0.66 4 1.46 0.47 10 
1.95 0.71 4 1.44 0.47 10 
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TABLE 4 
ANOVA Summary Table; 
Log ABC (repeated) by Progesterone and Estrogen Levels @ Day 0 
(Within Subjects) 




Estrogen x Progesterone 
Within Subjects Effects 
Within Cells 
Days 
Progesterone Level x Days 
Estrogen Level x Days 
Estrogen x Progesterone x Days 








































Mean Log ABC by Estrogen Levels @ Day 0 






B Estrogen (Low) @ Day 0 




This study explored the influence of estrous phase in female rats on antibody 
responses to a protein antigen. The intent was to examine the potential influence of 
the sex honnones estrogen and progesterone, associated with estrous, using a 
biologically intact system. Unlike previous investigations in this area, which have 
typically examined sex honnone influences in ovariectomized or neonatally 
castrated subjects, the design and methodology of the current investigation 
translates to the least amount of invasive procedures possible, such that the natural 
state of the animal may be preserved and observed accordingly. The current 
investigation was also designed to examine the role of estrous stage at the time of an 
immune system challenge as a critical factor in influencing the subsequent 
development of an immune response, as well as the role of estrous stage at any time 
during the development of an immune response as a critical factor in influencing that 
response. We proposed that the relative levels of estrogen and progesterone, as 
inferred from estrous phase, would influence the magnitude of humoral immune 
responding and that specific conditions (baseline and subsequent levels of estrogen, 
progesterone ) would be associated with discrete and hormone-specific fluctuations 
in immunity. 
Statistical analyses of the cross-sectionally sampled groups revealed an 
effect of increased magnitude of immune responding over time. The observed 
difference is an inlierent characteristic of the development of a secondary immune 
response, which typically proceeds from an arbitrary zero at time of injection, 
follows a gradual upward slope as the appropriate antigen-specific immune cells 
are produced and recmited, and then rises abmptly to asymptote once the 
antibodies have reached maximum titre. Further analyses of the cross-sectionally 
sampled groups, categorized according to relevant estrous phase clustering. 
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(estrogen high/low and progesterone liigMow), revealed no differences in antigen 
binding capacity. Analyses using these categories, which reflect estrogen and 
progesterone levels across time of second antigen delivery and time of testing, 
showed that the level of progesterone at time of testing approached significance (p 
= .071), with lower antigen binding capacity associated with higher progesterone 
levels. This tendency is consistent with other reports of an immunosuppressive 
influence from progesterone (Munroe, 1971; Nicol & Vemon-Roberts, 1965; 
Bratanov & Vulchanov, 1986). 
Analyses of longitudinal measures indicated a relationship between 
estrogen status (as inferred by estrous phase at the time of secondary 
injection) and measures of antigen binding capacity. Females with estrogen- 
dominant honnonal status, at time of injection, demonstrated greater 
magnitude of humoral immune responding than those with diminished 
estrogen at time of injection (as indicated by relatively higher and lower 
magnitude of antigen binding capacity, respectively). Progesterone status at 
time of antigen injection did not influence the magnitude of subsequent 
humoral response. 
It is unclear why the significant results obtained in the longitudinal 
design were not supported by the cross-sectional design. The two designs 
were focused on the effects of the estrous phase at two different times: time 
of testing versus time of antigen delivery. The inconsistency raises questions 
about the strength and generality of the estrous effects, and therefore creates 
caution in generalizing from the longitudinal design. 
These observations are consistent with reports showing that challenges to the 
immune system (such as injection of antigen) influence subsequent immune response 
and that this response is dependent upon endocrine status at the time of the challenge 
(Dukor and Dietrich, 1968). The importance of timing of the delivery of behavioral/ 
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phamiacological immune-altering treatment, relative to initiation of the immune 
response through antigen injection, was shown by Esterling and Rabin's (1987) in their 
investigation of the effects of rotational stress on splenic antibody production to SRBC 
antigen. The mice were either exposed to rotational stress and injected with the antigen 
simultaneously or stressed 24 hours following injection of the antigen. Timing of 
antigen injection relative to stress treatment, proved to be critical: antibody levels in 
mice exposed to stress 24 hours following antigen injection were 50 % lower than the 
mice stressed and injected with the antigen simultaneously. Mice and rats are valid 
models for studying endocrine and immune correlates of estrous (Nicol and Vemon- 
Roberts, 1965). In an investigation of endocrine changes which precede and follow 
immune responding, Pierpaoli and Maestroni (1977) administered a combination of 
drugs, phentolamine, haloperidol and 5HTP (L-5-hydroxytryptophan), as well as the 
honnones LH (leutenizing hormone), FSH (follicle stimulating honnone) and ACTH 
(adrenocorticotrophic honnone), to male and female mice. They measured antibody 
responses in the spleen to sheep red blood cells (SRBC) following the administration of 
the drug combination. They also measured LH and FSH levels before and after 
injection of SRBC antigen. The results showed that LH and FSH levels increased 
significantly following injection of SRBC. The combination of drugs phentolamine, 
haloperidol and 5HTP, which act centrally on the noradrenergic, dopaminergic and 
serotonergic neurotransmitter systems, respectively, completely prevented antibody 
production to SRBC. Pretreatment, but not subsequent injection, of LH, FSH and 
ACTH inhibited SRBC antibody production. The investigators hypothesized that the 
secretion of hormones involved in the initiation of the antibody response to SRBC 
could be effectively blocked by a combination of drugs acting in the central nervous 
system, likely at the level of the hypothalamus. This would support a central nervous 
system mediated mechanism whereby the sex hormones estrogen and progesterone may 
modulate immune ftmction. 
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The literature examining the interactions of sex steroids and immunity 
implicate estrogen, as the source of, or at least major contributant to the observed 
female immunological superiority. Results of the current investigation support the 
findings that estrogen status at the time of an immune system challenge is a critical 
deteraiinant of the immune response that ensues. Although quantitative differences 
in immunity at various stages of the estrous cycle in mice have been observed 
(Krzych et al. 1978), such differences were not observed in the current 
investigation. The absence of coherence between the findings of Krzych et al 
1978, and the findings of the current investigation may be attributable to a number 
of variables, including design and/or antigen and immune assay differences. 
Additionally, the validity of the findings in the current study may have been 
influenced by insufficient or uneven subject representation in each of the four 
estrous stages. Generally, a large proportion of studies exploring the influence of 
sex honnones on immune function have measured cellular immune function, 
compared with the measurement of humoral immune function, specifically in 
response to a protein antigen, as was used in this study. Cellular immune fiinction 
may be more susceptible to the transient fluctuations of ovarian steroids that 
accompany estrous, whereas the influence on antibody production is less robust 
and influenced longitudinally, as was observed in this investigation. 
Inconsistencies within the measurement of either cellular or humoral immune 
responses may stem from variable sensitivity of the measurement assay as well as 
differences in sensitivity among subsets of immune system cells. These possible 
sources of inconsistency aside, in the absence of observations of fluctuations in 
immunity during discrete, hormonally-distinct stages of the estrous cycle, the 
current findings support a phylogenetic origin of the superior and more variable 
immunocapacity of females. 
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Further study is required to fully understand the influence of sex hormones 
on immunity, particularly given the range and complexity of interrelationships 
among the endocrine, immune, and central nervous systems. Subsequent research in 
this area should diverge with refinement of the roles of other physiological systems 
involved in the steroidal modulation of immunity, and converge with a focus at the 
cell and the gene level of interaction between steroids and the immune system. 
The implications of the effect of endogenous endocrine status as a determinant of 
subsequent immune response are extensive, and raise possibilities for fliture research 
not only in the broad area of stress-induced immunosuppression, but also in the 
growing field of women's health. An enlianced understanding of the influence of 
hormonal status, stress, the influence of other physiological systems and their 
interactions, will lead to improved preventative and prophylactic strategies in 
women's health care. 
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